A TGF␤ signal transduction cascade controls body size and male tail morphogenesis in the nematode Caenorhabditis elegans. We have analyzed the function of the sma-3 Smad gene, one of three Smad genes that function in this pathway. Null mutations in sma-3 are at least as severe as null mutations in the ligand and type I receptor genes, dbl-1 and sma-6, indicating that the other Smads do not function in the absence of SMA-3. Furthermore, null mutations in sma-3 do not cause defects in egg laying or in regulation of the developmentally arrested dauer larva stage, indicating no overlapping function with another C. elegans TGF␤ signaling pathway. The sma-3 gene is widely expressed at all developmental stages in hermaphrodites and males. The molecular lesions associated with eight sma-3 alleles of varying severity have been determined. The missense mutations cluster in two previously identified regions important for Smad function.
INTRODUCTION
In the nematode Caenorhabditis elegans, a member of the transforming growth factor ␤ (TGF␤) superfamily, DBL-1, controls body size, aspects of male tail morphogenesis, and sensory neuron neurotransmitter expression (Suzuki et al., 1999; Morita et al., 1999; Lints et al., 1999) . DBL-1, a BMP (bone morphogenetic protein) homolog, initiates a TGF␤ signal transduction cascade comprising the type I receptor SMA-6 , the type II receptor DAF-4 (Estevez et al., 1993) , and the Smads SMA-2, SMA-3, and SMA-4 (Savage et al., 1996) . Mutants defective in this pathway, the Sma/Mab pathway, are ϳ50% smaller than wild type, have crumpled male copulatory spicules, and have defects in the patterning and neurotransmitter expression of male sensory rays. A second TGF␤ signaling pathway, the Dauer pathway initiated by the TGF␤ homolog DAF-7, controls entry into the developmentally arrested dauer larva stage and egg laying (Ren et al., 1996; Trent et al., 1983) . The type II receptor DAF-4 is required for both pathways, but other signaling components are thought to function specifically in one pathway or the other.
Smads are intracellular signaling mediators that function in TGF␤ signaling cascades (reviewed in Derynck et al., 1998; Padgett et al., 1998) . Three classes of Smads with functional and sequence differences are recognized: receptor-regulated (R-Smads), common (Co-Smads), and antagonistic (Anti-Smads). R-Smads, which include C. elegans SMA-2 and SMA-3, Drosophila MAD and Smad2, and vertebrate Smad1, Smad2, Smad3, and Smad5, are directly phosphorylated and activated by type I receptor kinase activity (Macías-Silva et al., 1996; Zhang et al., 1996; Kretzchmar et al., 1997; Das et al., 1999) . Upon activation, R-Smads form hetero-oligomeric complexes with Co-Smads, which include C. elegans SMA-4, Drosophila MEDEA, and vertebrate Smad4, and translocate to the nucleus (Lagna et al., 1996; Zhang et al., 1996; Kretzchmar et al., 1997; Wu et al., 1997) . Smad complexes act as transcription factors on regulated target genes through direct DNA binding and cooperation with other transcription factors (Chen et al., 1996 Kim et al., 1997; Liu et al., 1997) .
Smad proteins are 400 -600 amino acids in length and are characterized by two highly conserved domains of ϳ150 amino acids, MH1 and MH2, separated by a more divergent proline-rich linker. The MH1 N-terminal domain has DNA-binding and regulatory functions Kim et al., 1997; Shi et al., 1998) . The MH2 C-terminal domain is required for homo-and hetero-oligomerization and transcriptional activation (Liu et al., 1996; Hata et al., 1997; Shi et al., 1997) . The crystal structures of both the MH1 and the MH2 domains have been determined, providing additional insight into how the Smad proteins achieve their functions (Shi et al., 1997 .
We have analyzed the structure and function of the C. elegans sma-3 Smad gene, by determining its null phenotype and characterizing an allelic series. We have characterized the expression pattern of the sma-3 gene to investigate its site of action. Finally, we have determined the molecular lesions associated with eight sma-3 alleles. Our results indicate a critical and specific role for sma-3 in DBL-1/SMA-6 signaling and are consistent with the location of previously identified structural regions important for Smad function.
MATERIALS AND METHODS
Nematode strains. Methods for the culturing and genetic manipulation of C. elegans were as described (Brenner, 1974) . In addition to sma-3 alleles described, the following mutations and strains were used in these studies: dbl-1(wk70), sma-2(e502), sma-3(e491), sma-3(e637), sma-3(e958), sma-4(e729), sma-6(wk7), unc-32(e189), unc-36(e251), him-8(e1489), him-5(e1490), nDf16/ qC1[dpy-19glp-1], nDf16/dpy-17unc-32. sma-3 genetic analyses. Five alleles of sma-3, wk20, wk21, wk24, wk27, and wk28, were isolated in a genetic screen for Small mutants (C.S.-D. and R.W.P., unpublished data) and identified by their failure to complement sma-3(e491). To allow the identification of potentially lethal mutations in sma-3, a noncomplementation screen was performed. unc-36(e251) hermaphrodites were mutagenized with EMS and mated with heterozygous sma-3(e491)unc-32(e189)/ϩϩ males. F1 progeny were screened for Small non-Uncoordinated animals, indicating a new allele of sma-3 on the mutagenized unc-36 chromosome. One new allele, wk30, was isolated from 10,000 mutagenized haploid genomes.
Hemizygous sma-3 mutants were constructed for five alleles. Heterozygous sma-3/ϩ or sma-3unc-32/ϩϩ males were mated with nDf16/qC1 or nDf16/dpy-17unc-32 hermaphrodites. To determine the viability of sma-3/Df animals, male progeny were scored for the proportion of Small animals. For the qC1 strain, 35 Small males were found in 183 males scored. For the dpy-17unc-32 strain crossed with sma-3unc-32, 57 Uncoordinated, 92 wild-type, and 35 Small males were found. In each case, the number of Small animals was somewhat less than expected. As a control, the viability of unc-36/Df animals was also determined. From unc-36/ϩ males crossed with nDf16/qC1 hermaphrodites, 16 Uncoordinated males were found in 102 males scored. This result suggests that the reduced viability of sma-3/Df animals is not due to lowered dosage of sma-3, but to reduced viability of deficiency heterozygotes in general. To characterize the male tail phenotype of sma-3/Df animals, individual Small males from the cross were picked and examined by Nomarski microscopy.
Growth curves. Gravid hermaphrodites were washed off plates with M9 buffer and collected in an Eppendorf tube. Hermaphrodites were destroyed with sodium hypochlorite solution, leaving eggs that were collected and inoculated onto plates with bacteria. Larvae hatched from these eggs were collected at 12, 24, 48, 72, and 96 h and photographed. The length of individual worms was measured using SigmaScan software, and the results were graphed using SigmaPlot. At least 30 nematodes were measured for each time point.
sma-3 molecular analyses. A sma-3ϻlacZ reporter construct, HW2, was generated by amplifying 2.8 kb of genomic DNA upstream of the sma-3 ATG initiator codon and cloning into the lacZ vector pPD89.03 (A. Fire, personal communication). This construct was introduced into him-5 nematodes with the cotransformation marker rol-6 by microinjection (Mello et al., 1992) and integrated by ␥-irradiation. To sequence sma-3 alleles, the sma-3 gene (3 kb genomic DNA) was amplified by PCR from lysed worms. The PCR fragments were cloned into pBluescript, and at least two clones were sequenced for each mutant as described previously (Savage et al., 1996) .
RESULTS AND DISCUSSION

sma-3 Is Specifically Required for Body Size Determination and Male Tail Patterning
Most sma-3 alleles were isolated in genetic screens that allowed the recovery of only viable mutants. Since TGF␤ family ligands often have essential roles in other organisms, we sought to determine whether more severe or lethal alleles of sma-3 could be isolated. The characterization of complete loss-of-function (null) alleles of sma-3 also addresses the question of whether SMA-3 is a pathwayrestricted or common Smad. We used an unbiased genetic screen (Materials and Methods) to identify mutations that fail to complement sma-3(e491). One new sma-3 allele, wk30, was isolated in this screen. This allele contains a premature stop codon (see below). sma-3(wk30) shows no more severe phenotype than other strong sma-3 alleles. Neither sma-3(wk30) nor any other sma-3 mutants show any appreciable effects on dauer larva formation or egglaying behavior. Specifically, we have never seen dauer larvae on plates with sufficient food, and animals do not become noticeably bloated due to retention of eggs (n Ͼ 1000 for each allele; data not shown). These results confirm the identification of sma-3 as a pathway-restricted Smad.
sma-3 Mutant Phenotypic Classes
sma-3 alleles can be grouped into three phenotypic classes, weak, intermediate, and strong, based on the severity of the Male-abnormal phenotype. The wild-type C. elegans male tail contains nine pairs of sensory rays arranged in a precise spatial array. Each of the nine rays has a unique identity that we assayed by ray position and shape and position of ray opening, as described previously (Savage et al., 1996) . In TGF␤-signaling mutants, defects in specification of ray identity lead to particular ray fusions. In strong sma-3 alleles, rays 4 and 5 are fused 9 -22% of the time, rays 6 and 7 fuse 61-82% of the time, and rays 8 and 9 fuse 11-36% of the time (Table 1 ). The fused rays show characteristics of ray 4, ray 6, and ray 8, respectively: rays 4 and 8 opening ventrally and ray 6 shaped conically with no perceivable opening. Occasionally, transformations of ray 7 or ray 9 identity that are not accompanied by ray fusion occur (Table 1) .
Four of nine sma-3 alleles result in the strong phenotype. Two alleles show very low penetrance (Ͻ10%) of the ray fusion defects and are classified as weak. Three alleles are classified as intermediate because they show intermediate frequencies of either ray 6 -7 or ray 8 -9 fusions. The phenotypes of hemizygous animals (sma-3/Df) are not significantly different from the phenotypes of the corresponding homozygotes for most alleles tested (Student's t test, P Ͼ 0.05; data not shown). In contrast, the weak allele, wk20, gives a more severe phenotype when placed in trans to a chromosomal deficiency (P ϭ 0.01; Table 1 ).
In most cases, the phenotypes in sma-3 alleles are consistent with different tissues requiring different threshold levels of sma-3 activity: body size Ͼ ray 7 Ͼ ray 9 Ͼ ray 5 (Table 1) . Differential requirements for sma-3 probably reflect differential requirements for TGF␤ signaling in these tissues, as has been suggested by similar findings in sma-4 and sma-6 mutants . Two intermediate sma-3 alleles, however, give frequencies of ray fusions that are inconsistent with this interpretation (Table 1) . sma-3(wk27) has defects in rays 5 and 7 of frequency similar to that of strong alleles (P Ͼ 0.05; data not shown), but no defects in ray 9. sma-3(e491) has only an intermediate frequency of ray 7 defects, similar to that of wk24 (P ϭ 0.74), but a significantly higher frequency of ray 5 fusions than wk24 (P ϭ 0.01). These two mutants thus act as though they have different levels of sma-3 function in different tissues. Possibly, the mutant proteins interact differently with other tissue-specific factors necessary for signal transduction. The wk27 mutation is a termination codon late in the SMA-3 coding region (amino acid 268); while the e491 mutation is a missense mutation in MH2 (see below). a In wild-type nematodes, rays 8 and 9 fuse at a frequency of ϳ5% and the fused ray has characteristics of ray 9, extending to the edge of the fan. In TGF␤-signaling mutants, the same frequency of ray 9-like fusion is seen, but an additional percentage of rays are fused showing characteristics of ray 8, opening at the ventral surface of the fan. For some mutants we distinguished between these two fates and for others we did not.
b From Savage et al. (1996) .
DBL-1 Signaling Requires Two R-Smads and One Co-Smad
It is well documented that TGF␤ signaling requires two classes of Smads: the receptor-regulated R-Smads, which are phosphorylated by type I receptors, and the Co-Smads, which form heteromeric complexes with phosphorylated R-Smads (reviewed in Derynck et al., 1998; Padgett et al., 1998) . In the Sma/Mab pathway, another level of complexity is seen in the involvement of two Smads of the R-Smad class, sma-2 and sma-3 (Savage et al., 1996) . We wondered whether SMA-2 and SMA-4 could transduce any detectable signal in vivo in the absence of SMA-3. In this case, sma-3 null mutations would be less severe than null mutations in dbl-1 and sma-6, the signal and type I receptor genes. In fact, the male tail phenotype of sma-3 mutants is more severe than that of dbl-1 or sma-6 mutants, although all three mutations are known nonsense mutations (Table 2) . To ask this question in another way, we compared the phenotypes of sma-3 single mutants with that of a Smad triple-mutant strain (Table 2) . Here, there is no significant difference in severity (P ϭ 0.82), indicating that mutating the other two Smads causes no further decrease in signaling.
We have characterized the Small phenotype of sma-3 and other Small mutants by determining their sizes at different times after hatching. sma-3 and other TGF␤ signaling mutants hatch as L1 larvae indistinguishable in size from wild-type larvae (Fig. 1 ). This contrasts with sma-1 mutant L1 larvae, which are ϳ50% smaller than wild type, consistent with the role of sma-1 in embryonic elongation rather than in TGF␤ signaling (McKeown et al., 1998) . sma-3 and other TGF␤-signaling mutants show defects in postembryonic growth, so that by adulthood these mutants are ϳ50% shorter than wild type ( Fig. 1 and data not shown) . As was seen in the male tail phenotype, the Small phenotype of sma-3 is more severe than that of dbl-1 or sma-6. Furthermore, the phenotype of the Smad triple is indistinguishable from those of dbl-1 and sma-6. Therefore, in body size determination as in male tail patterning SMA-2 and SMA-4 fail to function in the absence of SMA-3. The simplest inference from these results is the existence of a SMA-2/ SMA-3/SMA-4 heteromeric complex that transduces DBL-1/SMA-6 signals. Such a complex has already been detected for vertebrate Smad2, Smad3, and Smad4 (Nakao et al., 1997) . We suggest that the involvement of either one or two R-Smads in TGF␤ signaling pathways offers an additional means of altering the specificity of response. N2, dbl-1(wk70), sma-1(e30), sma-3(wk30), sma-6(wk7), and sma-4(e729)sma-3(e491)sma-2(e502);him-8(e1489) were measured; dbl-1, sma-3, and sma-6 alleles are known nonsense mutations ( Fig. 3 ; Krishna et al., 1999; Suzuki et al., 1999) . Time indicates the number of hours after collection of eggs from gravid hermaphrodites. At 12 h, most of the animals have hatched as L1 larvae, except for sma-1 mutants, which may take longer to hatch. By 96 h, all of the animals are adults. The error bars indicate the standard deviation of the data.
We have determined the expression pattern of the sma-3 gene using a promoter fusion to the lacZ coding region. This construct is expressed widely at all developmental stages (Fig. 2) . Expression begins during embryogenesis (data not shown), continues through all larval stages (Fig.  2B) , and is very strong in adult hermaphrodites ( Fig. 2A) and males (Fig. 2C) . The type I receptor gene sma-6 is expressed in intestine, pharynx, and other tissues and overlaps the sma-3 pattern . In contrast, dbl-1 expression is restricted primarily to neurons in the ventral nerve cord and the male tail (Suzuki et al., 1999) .
sma-3 Mutations
The molecular lesions associated with eight sma-3 alleles have been determined by DNA sequencing (Fig. 3) . One weak allele, e958, contained no mutation in sma-3 coding regions; potential regulatory regions were not sequenced. Two of four strong alleles, e637 and wk30, are nonsense mutations, supporting the conclusion that this class represents the null alleles. Two of three intermediate alleles, wk24 and wk27, are also nonsense mutations, but these mutations terminate near the C-terminus of the protein.
Smad proteins are characterized by two highly conserved domains of ϳ150 amino acids, MH1 and MH2. The majority of reported Smad mutations map to the MH2 domain (Hata et al., 1998) . Four of the sma-3 mutations alter conserved amino acid residues in these two domains. One 
FIG. 4.
Mapping sma-3 mutations on Smad4 MH2 domain crystal structure (Shi et al., 1997) . The L3 loop is highlighted in red, and the positions of the e491 (G348R), wk28 (P360L), and wk21 (C361Y) mutations are highlighted in green. weak allele, wk20, has a missense mutation in a conserved amino acid in the MH1 domain. This mutation borders one of the loops of the double-loop region identified as a potential functional surface important for Smad activity . Other reported Smad mutations similarly affect this double loop region in MH1 (Hata et al., 1998) . The three strong and intermediate mutations cluster in the L3 loop of MH2: e491 (G348R), wk28 (P360L), and wk21 (C361Y) each alter conserved amino acid residues in this loop (Fig. 4) . The L3 loop forms an exposed surface that is thought to mediate interactions between Smads and other proteins and to determine the specificity of Smad interactions with TGF␤ receptors (Shi et al., 1997; Lo et al., 1998) . Because these three sma-3 mutations affect conserved residues, they are likely to interfere with conserved functions of the L3 loop, rather than altering the specificity of interactions. Furthermore, mutations in the L3 loop do not affect homo-oligomerization (Shi et al., 1997) . Therefore, these SMA-3 mutant proteins are probably deficient in other protein-protein interactions necessary to their function. This conclusion is consistent with our finding that e491 shows tissue-specificity in its severity, indicating that the mutant protein may have differential interactions with tissue-specific cofactors. Our results thus confirm the significance of these Smad structural elements in the context of a developmental pathway.
